Siga Technologies INC Deferred Tax Liabilities, Goodwill
Siga Technologies INC (SIGA) had Deferred Tax Liabilities, Goodwill of $203.04 thousand as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill · last filed 2026-03-10
- 2025-12-31: Deferred Tax Liabilities, Goodwill $203.04K.
- 2024-12-31: Deferred Tax Liabilities, Goodwill $194.09K.
- 2023-12-31: Deferred Tax Liabilities, Goodwill $192.13K.
- 2022-12-31: Deferred Tax Liabilities, Goodwill $192.08K.
| Period end | Deferred Tax Liabilities, Goodwill |
|---|---|
| 2025-12-31 | $203.04K 10-K · filed 2026-03-10 |
| 2024-12-31 | $194.09K 10-K · filed 2026-03-10 |
| 2023-12-31 | $192.13K 10-K · filed 2025-03-11 |
| 2022-12-31 | $192.08K 10-K · filed 2024-03-12 |
| 2021-12-31 | $197.25K 10-K · filed 2023-03-02 |
| 2020-12-31 | $199.17K 10-K · filed 2022-03-03 |
| 2019-12-31 | $201.93K 10-K · filed 2021-03-04 |
| 2018-12-31 | $192.15K 10-K · filed 2020-03-05 |
| 2017-12-31 | $193.46K 10-K · filed 2019-03-06 |
| 2016-12-31 | $287.73K 10-K · filed 2018-03-06 |
| 2015-12-31 | $267.60K 10-K · filed 2017-03-07 |
| 2014-12-31 | $244.54K 10-K · filed 2016-03-04 |
| 2013-12-31 | $224.91K 10-K · filed 2015-03-06 |
| 2012-12-31 | $203.68K 10-K · filed 2014-03-10 |
| 2011-12-31 | $183.37K 10-K/A · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |